1. Home
  2. CLBK vs BHVN Comparison

CLBK vs BHVN Comparison

Compare CLBK & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Columbia Financial Inc.

CLBK

Columbia Financial Inc.

HOLD

Current Price

$21.28

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

BHVN

Biohaven Ltd.

HOLD

Current Price

$15.56

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLBK
BHVN
Founded
1927
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.0B
IPO Year
2017
2022

Fundamental Metrics

Financial Performance
Metric
CLBK
BHVN
Price
$21.28
$15.56
Analyst Decision
Hold
Buy
Analyst Count
1
14
Target Price
$17.00
$29.08
AVG Volume (30 Days)
442.6K
3.9M
Earning Date
04-20-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
563.64
26.08
EPS
0.13
N/A
Revenue
N/A
N/A
Revenue This Year
$3.97
N/A
Revenue Next Year
$11.43
N/A
P/E Ratio
$162.85
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.66
$7.48
52 Week High
$21.59
$18.57

Technical Indicators

Market Signals
Indicator
CLBK
BHVN
Relative Strength Index (RSI) 60.99 60.84
Support Level $19.63 $14.44
Resistance Level $21.39 $16.74
Average True Range (ATR) 0.46 1.10
MACD 0.03 -0.01
Stochastic Oscillator 86.70 49.23

Price Performance

Historical Comparison
CLBK
BHVN

About CLBK Columbia Financial Inc.

Columbia Financial Inc is a federally chartered savings bank that serves the financial needs of depositors and the local community as a customer service-focused institution. The company offers traditional financial services to businesses and consumers in its market areas. It attracts deposits from the general public and uses those funds to originate various loans, including multifamily and commercial real estate loans, commercial business loans, one-to-four family real estate loans, construction loans, home equity loans and advances, and other consumer loans. The company also offers title insurance through its wholly owned subsidiary and provides a broad range of insurance products, including personal and business lines of insurance, mainly to customers and New Jersey residents.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: